Standout Papers
- Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial (2022)
- Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion (2019)
Citation Impact
1 by Nobel laureates 70 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Works of Minke He being referenced
A phase II trial of lenvatinib plus toripalimab and hepatic arterial infusion chemotherapy as a first-line treatment for advanced hepatocellular carcinoma (LTHAIC study).
2021
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
2019 Standout
Author Peers
| Author | PFM | Hepatology | PRM | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Minke He | 398 | 754 | 221 | 307 | 39 | 1.0k | |
| Qilong Ren | 1 | 8 | 4 | 17 | 399 | ||
| Johannes Eckerth | 10 | 214 | |||||
| Peter H. Howard | 12 | 342 | |||||
| B.R. Payne | 2 | 18 | 537 | ||||
| Sharon Orbach‐Zinger | 42 | 1 | 16 | 383 | 73 | 739 |
All Works
Loading papers...